Edit
INBRAIN NEUROELECTRONICS
http://www.inbrain-neuroelectronics.com/Last activity: 31.10.2024
Active
By using graphene, the thinnest material known to mankind, INBRAIN is developing smart brain interfaces that will improve the quality of life for millions of people around the world.
In Europe alone, up to 35 percent of the population is affected by brain disorders, causing not only considerable suffering but also costs of up to 800 billion euros per year. It is known that brain implants can be used to treat patients with epilepsy, Parkinson’s, and other brain related disease. However, existing interfaces are metal based with considerable restrictions for miniaturization and signal resolution, therefore limiting their therapeutic effect and causing side effects.
INBRAIN’s technology overcomes these shortcomings. The use of the revolutionary material graphene enables the design of a less invasive brain interface with nanoscale electrodes, decisively reducing side effects. The wireless system decodes brain signals with unprecedented ultra-high signal resolution. Through machine learning, the implant adapts to each individual patient, delivering personalized therapy.
In Europe alone, up to 35 percent of the population is affected by brain disorders, causing not only considerable suffering but also costs of up to 800 billion euros per year. It is known that brain implants can be used to treat patients with epilepsy, Parkinson’s, and other brain related disease. However, existing interfaces are metal based with considerable restrictions for miniaturization and signal resolution, therefore limiting their therapeutic effect and causing side effects.
INBRAIN’s technology overcomes these shortcomings. The use of the revolutionary material graphene enables the design of a less invasive brain interface with nanoscale electrodes, decisively reducing side effects. The wireless system decodes brain signals with unprecedented ultra-high signal resolution. Through machine learning, the implant adapts to each individual patient, delivering personalized therapy.
Total raised: $85.62M
Investors 2
Date | Name | Website |
- | Vsquared V... | vsquared.v... |
- | Alta Life ... | altals.com... |
Funding Rounds 3
Date | Series | Amount | Investors |
30.10.2024 | Series B | $50M | - |
20.12.2022 | - | $18.62M | - |
31.03.2021 | Series A | $17M | Alta Life ... |
Mentions in press and media 17
Date | Title | Description |
31.10.2024 | INBRAIN Neuroelectronics: Pioneering the Future of Brain-Computer Interfaces | In the world of neuroscience, a quiet revolution is brewing. INBRAIN Neuroelectronics, a Barcelona-based company, is at the forefront of this change. Recently, they secured $50 million in Series B funding, pushing their total capital raised... |
30.10.2024 | INBRAIN Neuroelectronics: Brain-Computer Interface Therapeutics Company Secures $50 Million (Series B) | INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, announced the closing of a $50 million Series B funding round. The funding round was led by imec.xpand with ne... |
29.10.2024 | INBRAIN Neuroelectronics Raises $50M in Series B Funding | INBRAIN Neuroelectronics, a Barcelona, Spain-based brain-computer interface therapeutics (BCI-Tx) company, raised $50M in Series B funding. The round, which brought the total amount to $68M, was led by imec.xpand with new investors EIC Fund... |
08.08.2024 | EU-Startups Podcast | Episode 80: Benedikt von Schoeler, General Partner of Vsquared Ventures | In this episode, we catch up with Benedikt von Schoeler, General Partner of VSquared Ventures, a leading early-stage Deep Tech fund, backing some of Europe’s most promising Deep Tech companies, including Isar Aerospace, Zama, IQM Quantum, I... |
20.12.2022 | INBRAIN, backed by national and international VCs, receives €17.5M from the European EIC Accelerator | 19/12/2022 Post INBRAIN, BACKED BY NATIONAL AND INTERNATIONAL VCs, RECEIVES 17.5M EUROS FROM THE EUROPEAN EIC ACCELERATOR INBRAIN receives 17.5M Euros from the European EIC Accelerator to continue the development of the world’s first gra... |
07.09.2021 | BStartup lanza la IV convocatoria del programa BStartup Health de apoyo a proyectos de Salud en fases pre-seed y seed | 07/09/2021 Nota de prensa BSTARTUP LANZA LA IV CONVOCATORIA DEL PROGRAMA BSTARTUP HEALTH DE APOYO A PROYECTOS DE SALUD EN FASES PRE-SEED Y SEED. Queremos ser tu socio Banco Sabadell invierte en startups con una filosofía centrada en el ... |
08.04.2021 | CDTI Innvierte aprueba nuevas coinversiones por €20,7 millones | 08/04/2021 Nota de prensa CDTI INNVIERTE APRUEBA NUEVAS COINVERSIONES POR €20,7 MILLONES. El CDTI, adscrita al Ministerio de Ciencia e Innovación, como promotor del programa Innvierte y accionista único de esta sociedad, ha cerrado en el... |
31.03.2021 | Inbrain Neuroelectronics Secures $17M in Series A Funding | Inbrain Neuroelectronics S.L., a Barcelona, Spain-based company dedicated to developing an intelligent graphene-brain interface, raised $16.8m in Series A funding. The round was co-led by Asabys Partners and Alta Life Sciences, and joined b... |
26.03.2021 | INBRAIN Neuroelectronics raises over €14M Series A led by Asabys Partners, Alta Life Sciences and CDTI to develop intelligent graphene-based neuroelectronic therapies for brain related disorders | INBRAIN Neuroelectronics is a spin-off company from Graphene Flaship partners’ the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA, established in 2019 in the intersection between Medtech, DeepTech and Digital Hea... |
26.03.2021 | INBRAIN Neuroelectronics raises over €14M Series A led by Alta Life Sciences, Asabys Partners and CDTI to develop intelligent graphene-based neuroelectronic therapies for brain related disorders | Barcelona, March 26th , 2021 INBRAIN Neuroelectronics is a spin-off company from Graphene Flaship partners’ the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA, established in 2019 in the intersection between Medtech, ... |
Show more